Abstract

Psychotic symptoms are not only an important feature of severe neuropsychiatric disorders, but are also common in the general population, especially in youth. The genetic etiology of psychosis symptoms in youth remains poorly understood. To characterize genetic risk for psychosis spectrum symptoms (PS), we leverage a community-based multiethnic sample of children and adolescents aged 8–22 years, the Philadelphia Neurodevelopmental Cohort (n = 7225, 20% PS). Using an elastic net regression model, we aim to classify PS status using polygenic scores (PGS) based on a range of heritable psychiatric and brain-related traits in a multi-PGS model. We also perform univariate PGS associations and evaluate age-specific effects. The multi-PGS analyses do not improve prediction of PS status over univariate models, but reveal that the attention deficit hyperactivity disorder (ADHD) PGS is robustly and uniquely associated with PS (OR 1.12 (1.05, 1.18) P = 0.0003). This association is driven by subjects of European ancestry (OR = 1.23 (1.14, 1.34), P = 4.15 × 10−7) but is not observed in African American subjects (P = 0.65). We find a significant interaction of ADHD PGS with age (P = 0.01), with a stronger association in younger children. The association is independent of phenotypic overlap between ADHD and PS, not indirectly driven by substance use or childhood trauma, and appears to be specific to PS rather than reflecting general psychopathology in youth. In an independent sample, we replicate an increased ADHD PGS in 328 youth at clinical high risk for psychosis, compared to 216 unaffected controls (OR 1.06, CI(1.01, 1.11), P = 0.02). Our findings suggest that PS in youth may reflect a different genetic etiology than psychotic symptoms in adulthood, one more akin to ADHD, and shed light on how genetic risk can be investigated across early disease trajectories.

Details

Title
Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD
Author
Olde Loohuis Loes M 1   VIAFID ORCID Logo  ; Mennigen Eva 2 ; Ori, Anil P, S 1 ; Perkins, Diana 3 ; Robinson, Elise 4 ; Addington, Jean 5   VIAFID ORCID Logo  ; Cadenhead, Kristin S 6 ; Cornblatt, Barbara A 7 ; Mathalon, Daniel H 8 ; McGlashan, Thomas H 9 ; Seidman, Larry J 10 ; Keshavan Matcheri S 10 ; Stone, William S 10 ; Tsuang, Ming T 6   VIAFID ORCID Logo  ; Walker, Elaine F 11 ; Woods, Scott W 9 ; Cannon, Tyrone D 12 ; Gur, Ruben C 13 ; Gur, Raquel E 13 ; Bearden, Carrie E 14   VIAFID ORCID Logo  ; Ophoff, Roel A 15   VIAFID ORCID Logo 

 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University Hospital Carl Gustav Carus, Technische Universität Dresden, Department of Psychiatry and Psychotherapy, Dresden, Germany (GRID:grid.19006.3e) 
 University of North Carolina, Department of Psychiatry, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720) 
 Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Broad Institute of MIT and Harvard, Program in Medical and Population Genetics, Cambridge, USA (GRID:grid.66859.34); Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Hotchkiss Brain Institute, Department of Psychiatry, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 Department of Psychiatry, UCSD, San Diego, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242) 
 Zucker Hillside Hospital, Department of Psychiatry, Long Island, USA (GRID:grid.440243.5) (ISNI:0000 0004 0453 5950) 
 UCSF, and SFVA Medical Center, Department of Psychiatry, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Yale University, Department of Psychiatry, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
10  Harvard Medical School at Beth Israel Deaconess Medical Center, Department of Psychiatry, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547) 
11  Emory University, Departments of Psychology and Psychiatry, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502) 
12  Yale University, Department of Psychology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
13  University of Pennsylvania School of Medicine and the Penn-CHOP Lifespan Brain Institute, Department of Psychiatry, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
14  University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Department of Psychology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
15  University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Department of Human Genetics, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Erasmus University Medical Center, Department of Psychiatry, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2482358614
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.